Skip to Main Content

Paper Details

Targeted Investigational Oncology Agents in the NCI-60: A Phenotypic Systems-based Resource.
Mol Cancer Ther
2
2023
NCI-60, NCI-60 human tumor cell line panel, NCI-60 panel, cancer, cell line, human, tumor

Datasets

Release 1.2